Introduction Uveal melanoma (UVM) is the most invasive intraocular malignancy in adults
with a poor prognosis. Growing evidence revealed that immune-related gene is related to …

Background To identify an immune-related prognostic signature and find potential
therapeutic targets for uveal melanoma. Methods The RNA-sequencing data obtained from …

Purpose The current study aimed to reveal a novel immune-related signature to evaluate
immune infiltration status and the survival outcome for patients with uveal melanoma (UM) …

Objectives Uveal melanoma (UM) is the most common primary intraocular malignancy in
adults, and immune infiltration plays a crucial role in the prognosis of UM. This study aimed …

Immunotherapy is the most promising treatment for uveal melanoma patients with
metastasis. Tumor microenvironment plays an essential role in tumor progression and …

Current immunotherapies are unsatisfactory against uveal melanoma (UM); however,
elevated CD8+ T cell infiltration level indicates poor prognosis in UM. Here, we aimed to …

Uveal melanoma (UM) is the most common primary intraocular malignant tumor in adults
and almost fifty percent of patients subsequently develop systemic metastases usually …

Molecular classification based on transcriptional characteristics is often used to study tumor
heterogeneity. Human cancer has different cell populations with distinct transcription in …

Uveal melanoma (UM) is a subtype of melanoma with poor prognosis. This study aimed to
construct a new prognostic gene signature that can be used for survival prediction and risk …

Uveal melanoma (UVM) is the most common primary intraocular cancer in adults. Increasing
evidence has demonstrated that immune cell infiltration (ICI) is crucial in predicting patient …